Hydroxylamines
- Name
- Hydroxylamines
- Accession Number
- DBCAT000393
- Description
Organic compounds that contain the (-NH2OH) radical.
- Drugs
Drug Drug Description 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide Not Available 4-Phospho-D-erythronohydroxamic acid Not Available 6-bromoindirubin-3'-oxime Not Available Abexinostat Abexinostat has been used in trials studying the treatment of Sarcoma, Lymphoma, Leukemia, Lymphocytic, and Hodgkin Disease, among others. It is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase... Acetohydroxamic acid A synthetic urea derivative used to treat urea splitting bacterial infections of the urinary tract. Adrafinil Used to relieve excessive sleepiness and inattention in elderly patients. Alilusem Alilusem is a small molecule drug. Alilusem has a monoisotopic molecular weight of 394.04 Da. Aminooxyacetic acid A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues. [PubChem] Ancriviroc Ancriviroc is a small molecule drug. The usage of the INN stem '-viroc' in the name indicates that Ancriviroc is a CCR5 (Chemokine CC motif receptor 5) receptor antagonist. Ancriviroc... Asoprisnil Investigated for use/treatment in uterine fibroids. Bb-3497 Not Available Belinostat A histone deacetylase (HDAC) inhibitor used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Beloxamide Beloxamide is a small molecule drug. Beloxamide has a monoisotopic molecular weight of 283.16 Da. Benurestat Benurestat is a small molecule drug. The usage of the INN stem '-restat' in the name indicates that Benurestat is a aldose reductase inhibitor. Benurestat has a monoisotopic molecular weight... Benzhydroxamic Acid Not Available Brasofensine For the treatment of Parkinson's Disease. Bufexamac An NSAID used to treat skin conditions like atopic eczema and inflammatory dermatoses. Caprylhydroxamic acid Not Annotated CGS-27023 Not Available Clovoxamine Clovoxamine is a small molecule drug. Clovoxamine has a monoisotopic molecular weight of 284.13 Da. Coprogen Not Available CTS-1027 CTS-1027 has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection. CUDC-101 CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer, and Gastric Cancer, among others. Dabrafenib A kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer. Dacinostat Dacinostat is a novel histone deacetylase inhibitor. Darapladib Investigated for use/treatment in atherosclerosis. Deferoxamine A chelating agent used to treat iron or aluminum toxicity and some blood transfusion dependent anemias. Diclofurime Diclofurime is a small molecule drug. Diclofurime has a monoisotopic molecular weight of 384.1 Da. Didox Didox has been used in trials studying the supportive care of Gastric Cancer. Enviroxime Enviroxime is a small molecule drug. Enviroxime has a monoisotopic molecular weight of 358.11 Da. Epacadostat Epacadostat has been used in trials studying the treatment of HL, Melanoma, Glioblastoma, Mucosal Melanoma, and Ovarian Carcinoma, among others. Filaminast Filaminast is a phosphodiesterase 4 inhibitor (PDE4 inhibitor). As such, has potential in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Fluvoxamine A selective serotonin-reuptake inhibitor used to treat obsessive-compulsive disorder. Gallichrome Not Available Givinostat A histone deacetylase inhibitor indicated for the treatment of Duchenne Muscular Dystrophy (DMD). Glucoraphanin Glucoraphanin is under investigation in clinical trial NCT01879878 (Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]). Glutamine hydroxamate Not Available GSK2256098 GSK2256098 is under investigation in clinical trial NCT02523014 (Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas). Ibuproxam Ibuproxam is a non steroidal anti-inflammatory drug (NSAID). Ilomastat Ilomastat is a broad-spectrum matrix metalloproteinase inhibitor. Indirubin-3'-monoxime Not Available Ivaltinostat Not Annotated Lanopepden Lanopepden has been used in trials studying the treatment of Pneumonia, Infections, Bacterial, Skin Diseases, Infectious, and Skin Infections, Bacterial. LX-2931 Investigated for use/treatment in rheumatoid arthritis, inflammatory disorders (unspecified), and autoimmune diseases. Marimastat For the treatment of various cancers Martinostat Martinostat is under investigation in clinical trial NCT03721211 (Imaging With [11C]Martinostat in Breast Cancer). Milameline Milameline is a small molecule drug. Milameline has a monoisotopic molecular weight of 154.11 Da. Nolasiban Nolasiban is under investigation in clinical trial NCT03081208 (Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI). Norelgestromin A progestin used as the progestational component of a transdermal combined hormonal contraceptive, preventing pregnancy primarily through suppression of ovulation. NP-51 Not Annotated Obidoxime Not Annotated Panobinostat A non-selective histone deacetylase inhibitor used to treat multiple myeloma in combination with other antineoplastic agents. PG-530742 Investigated for use/treatment in osteoarthritis. Pralidoxime A cholinesterase reactivator used to treat organophosphate poisoning. Pyroxamide Pyroxamide has been used in trials studying the treatment of Leukemia, Lymphoma, Small Intestine Cancer, Precancerous Condition, and Myelodysplastic Syndromes, among others. Quisinostat Quisinostat has been used in trials studying the treatment of Lymphoma, Neoplasms, Myelodysplastic Syndromes, and Advanced or Refractory Leukemia. R-306465 R306465 has been used in trials studying the treatment of Neoplasms. Reposal Reposal is a barbiturate derivative invented in the 1960s in Denmark that has sedative, hypnotic and anticonvulsant properties. It was used primarily in the treatment of insomnia. Resminostat Resminostat has been used in trials studying the treatment of Sezary Syndrome, Mycosis fungoides, Hodgkin's Lymphoma, Hepatocellular Carcinoma, and Lymphoma, T-Cell, Cutaneous, among others. Ricolinostat Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer. SC-74020 Not Available Sibrafiban Sibrafiban is a small molecule drug. The usage of the INN stem '-fiban' in the name indicates that Sibrafiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). Sibrafiban has... Solimastat Solimastat is a small molecule drug. The usage of the INN stem '-mastat' in the name indicates that Solimastat is a matrix metalloproteinase inhibitor. Solimastat has a monoisotopic molecular weight... Technetium Tc-99m exametazime A radiopharmaceutical diagnostic agent used as an adjunct for scintigraphy in the detection of altered regional cerebral perfusion in stroke. Tefinostat Tefinostat is under investigation in clinical trial NCT02759601 (Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)). Tosedostat Tosedostat has been used in trials studying the treatment and supportive care of AML, Leukemia, Pancreas Cancer, Multiple Myeloma, and Pancreatic Cancer, among others. Tosedostat is an inhibitor of the... Trichostatin A Not Available TRO40303 TRO40303 is under investigation in clinical trial NCT01374321 (Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction). Upamostat Upamostat has been used in trials studying the treatment of Pancreatic Cancer. Vorinostat A histone deacetylase (HDAC) inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies. WAY-151693 Not Available Xylarohydroxamate Not Available Zinviroxime Zinviroxime is a small molecule drug. Zinviroxime has a monoisotopic molecular weight of 358.11 Da. - Drugs & Drug Targets